Research.Patient.info
Active idiopathic inflammatory myopathies (IIM) research hub
2 indexed studies · 1 currently recruiting
- completedPhase II
A study of nipocalimab in participants with active idiopathic inflammatory myopathies
This study tests a new medicine called nipocalimab for adults with inflammatory muscle diseases. These rare conditions cause muscle weakness and pain. Researchers want to find out if nipocalimab works better than a dummy treatment to calm muscle inflammation and improve daily strength and movement.
United Kingdom · England · Australia - recruitingTherapeutic exploratory (Phase II)
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Nipocalimab in Participants with Active Idiopathic Inflammatory Myopathies
This study tests whether a new medicine called nipocalimab can help adults with active inflammatory muscle diseases (myositis). Researchers want to see if the medicine reduces muscle weakness and inflammation, while also allowing patients to safely lower their daily dose of steroid tablets over one year.
Hungary · Poland · Czechia